GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ndm-1 beta-lactamase in complex with broad spectrum boronic inhibitor cpd 1

Analyse Crystal structure of ndm-1 beta-lactamase in complex with broad spectrum… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6IBV
Type
protein
Length
455 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
C7C422
Ligands
H9E, ZN, CA, MG

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein227—C7C422
B—protein228—C7C422

Ligands and binding sites

  • H9E · [5-(bromomethyl)-1-benzothiophen-2-yl]-tris(oxidanyl) boranuide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • CA · Calcium ion · metal · 3 copies · chains A, B
  • MG · Magnesium ion · metal · chains B
  • DMS · Dimethyl sulfoxide · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6IBV · Crystal structure of NDM-1 beta-lactamase in complex with broad spectrum boronic… · the same entry in another collection · chain A against A, TM-score 1.00
  • C7C422 · AlphaFold monomer V2.0 prediction for metallo-beta-lactamase type 2 (C7C422) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.